Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
21,335 total articles
Micware Co., Ltd., a Japan-based software provider focused on automotive and mobility IT solutions, has announced the commencement of trading of its American Depositary Shares (ADSs) on the Nasdaq Global Market under the ticker symbol MWC. The listing marks Micware's entrance into the U.S. capital markets, supported by its strong OEM relationships …
ZenaTech, Inc. announces significant progress on its ZenaDrone 2000 heavy-lift interceptor drone, with manufacturing and system integration completed and initial flight testing scheduled for Q3 2026. The drone targets the growing $20 billion counter-drone defense market, offering gas-powered extended endurance, autonomous threat detection, and mult…
Corbus Pharmaceuticals has appointed Brent Pfeiffenberger, a seasoned pharma executive with extensive leadership roles at Bristol Myers Squibb and Century Therapeutics, to its Board of Directors. His expertise is expected to support Corbus’ ongoing development of its oncology treatment CRB-701 and obesity treatment CRB-913. The company anticipates …
SoundThinking, a NASDAQ-listed public safety tech company, announced David Jochim as their new Senior Vice President of TechnoLogic and Professional Services. Jochim is expected to strengthen operational discipline and grow the customer base for the TechnoLogic division, which supports the NYPD's Enterprise Case Management System and the CaseBuilde…
SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company focused on novel cancer therapies, announced that its President and CEO, Angelos Stergiou, will participate in several upcoming investor conferences in May 2026, where corporate presentations and fireside chats will be conducted. The company highlighted its lead drug …
Algorhythm Holdings, Inc. (NASDAQ: RIME) announced record first quarter 2026 financial results driven by a 71% sequential and 1,851% year-over-year revenue increase to $2.4 million, primarily from scaling its SemiCab AI-powered logistics business. The company strengthened its cash position to nearly $11 million, reduced net loss by 42%, and returne…
Diginex Limited, a Nasdaq-listed sustainable RegTech company, disclosed significant expansion initiatives including a $1.5 billion all-share proposal to acquire AI-driven Resulticks, over $100 million in acquisitions since its 2025 IPO, a $40 million strategic reseller agreement, and $25.4 million in founder share purchase. These moves aim to evolv…
Synergy CHC Corp., a US consumer health and wellness company, reported first quarter 2026 financial results showing a revenue decline to $5.49 million from $8.17 million year-over-year, primarily due to non-recurrence of license revenue and out-of-stock issues. However, its functional beverage segment showed strong momentum with revenues exceeding …
Merlin, Inc. announced its new Merlin Pilot for Commercial Cargo product, part of the Condor family, which integrates AI-powered autonomous technology into commercial cargo aircraft. This system aims to enhance safety and operational efficiency amid growing global air freight demand and pilot shortages, with ongoing collaborations and progress towa…
La Rosa Holdings Corp. announced ongoing progress in its proposed transaction with Consensus Core Technologies, with expected definitive agreements anticipated within 45 to 60 days, subject to customary conditions. The transaction aims to create strategic opportunities for both companies. La Rosa Holdings is a real estate and PropTech company opera…
Prenetics Global Limited announced preliminary Q1 2026 results showcasing a substantial revenue increase to $36 million, driven primarily by its IM8 brand which reported $33.8 million, reflecting 23.1% growth over Q4 2025 and nearly sixfold year-over-year growth. The company raised its full-year IM8 revenue guidance to $190 million to $210 million …
BranchOut Food Inc. achieved record production in March and Q2 2026, driven by a major order to the nation's second largest warehouse club retailer and expansion with the largest warehouse club retailer. The company anticipates Q2 to be a record revenue quarter fueled by these deliveries and a potential high-margin tolling partnership nearing compl…
Strive, Inc. announced it will begin paying daily dividends on its Variable Rate Series A Perpetual Preferred Stock (SATA) starting June 16, 2026, maintaining its annual dividend rate of 13%. The company reported first quarter 2026 financial results, including acquiring over 6,000 bitcoin in Q1 and an additional 1,381 bitcoin from April to May 2026…
Sunrise Realty Trust, Inc. announced its financial results for Q1 2026, reporting GAAP net income of $4.3 million and distributable earnings of $4.7 million. The company paid a $0.30 per share dividend, representing a continued commitment to shareholder returns. CEO Brian Sedrish highlighted attractive pipeline opportunities in transitional commerc…
Intuitive Machines reported strong first quarter 2026 financial results, highlighted by record quarterly revenue of $186.7 million, positive adjusted EBITDA, and backlog growth driven by the $800 million acquisition of Lanteris Space Systems. The acquisitions and new contracts with NASA, U.S. Space Force, and Space Development Agency position the c…
Agomab Therapeutics, a clinical-stage biopharmaceutical company specializing in fibro-inflammatory disease treatments, will participate in several prominent healthcare and investor conferences throughout 2026. The company will present preclinical data on its inhaled TGFβR1/ALK5 inhibitor aimed at treating idiopathic pulmonary fibrosis and engage in…
EDAP TMS S.A. announced a letter of intent with Telix Pharmaceuticals to collaborate on clinical research and physician education combining EDAP's Focal One Robotic HIFU therapy and Telix's PSMA PET imaging products for enhanced prostate cancer treatment. This partnership aims to integrate advanced imaging and robotic therapy to optimize treatment …
Electra Battery Materials Corporation reported significant progress in Q1 2026 on its cobalt sulfate refinery construction project in Ontario, Canada. The company approved a $73 million construction budget, awarded key contracts, secured a strategic supply agreement with LG Energy Solution, and obtained $20 million in government funding to support …
Cognition Therapeutics announced receipt of a second philanthropic donation that allows the continuation of its expanded access program (EAP) providing Zervimesine (CT1812) treatment to patients with Dementia with Lewy Bodies (DLB). The EAP, launched in 2025 and currently serving 32 participants, is now extended to two years of treatment. Positive …
Milestone Scientific Inc. announced its Q1 2026 financial results showing a 30% reduction in operating expenses, significantly narrowed operating loss, and stable revenue despite Middle East shipping challenges. Medical segment revenues more than doubled year-over-year. The company completed a $2.15 million financing in April 2026 to support growth…
BriaCell Therapeutics announced the completion of manufacturing clinical supplies for Bria-PROS+, its next-generation personalized off-the-shelf immunotherapy for prostate cancer. The company plans to initiate Phase 1/2a clinical trials in the coming months. Bria-PROS+ activates both adaptive and innate immunity and builds upon the successful Bria-…
MiNK Therapeutics has initiated a randomized Phase 2 clinical trial evaluating their off-the-shelf allogeneic invariant natural killer T (iNKT) cell therapy, agenT-797, in patients with severe acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). The study, conducted in partnership with First Lviv Territorial Medical Union and sup…
HCW Biologics announced that its immunotherapeutic candidate HCW11-040, a pembrolizumab-based fusion protein, successfully prevented bronchopulmonary dysplasia (BPD) in an animal model during IND-enabling studies. The company plans to complete these studies by late 2027 and file an IND application promptly to treat infants at high risk of BPD, a ra…
CorMedix Therapeutics reported robust financial results for Q1 2026 with net revenue of $127.4 million and net income of $38.6 million, driven by strong DefenCath sales and contribution from the Melinta acquisition. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, highlighting positive momentum and advancing late-stage cl…
Genie Energy Ltd. announced its Q1 2026 financial results showing record revenue growth to $142.3 million but significant declines in gross profit, operating income, and adjusted EBITDA due to margin compression and higher customer acquisition costs. The company lowered its full-year 2026 adjusted EBITDA guidance citing ongoing margin pressures and…
